Uroplasty Reports First Fiscal Quarter Results
...t the beginning of the fiscal year of growing U.S. macroplastique
sales and accumulating the clinical data for seeki...ow year-ago results, we are encouraged by our U.S. macroplastique
sales that have doubled from last year's fiscal first quarter. Our European macroplastique
sales were impacted by a recently resolved distrib...
Urgent(R) PC and Macroplastique(R) Featured in Numerous IUGA 2009 Sessions
...dium and poster presentations and workshops."
presentations at the IUGA annual meeting included:...London, England. The findings supported the use of macroplastique
or retropubic mid-urethral tape as cost effective ...ents for stress urinary incontinence and suggested macroplastique
may offer additional savings in terms of cost to t...
Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results
...ournal of Urology ," added Mr. Kaysen. "Our U.S. macroplastique
sales grew by 191%, as compared to fiscal 2008. I...hlights the clinical and competitive advantages of macroplastique
and we are pleased to report that Aetna has recently initiated coverage for macroplastique
procedures. While our European momentum with...
Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009
...d with overactive bladder. The system is an office-based,
nonsurgical, percutaneous tibial nerve stimulation (PTNS) device that
treats these symptoms. macroplastique
is an injectable urethral bulking
agent for the treatment of adult-female stress-urinary incontinence
primarily due to intrinsic sphincter deficiency....
Uroplasty to Highlight Urgent PC System at American Urological Association 2008 Annual Meeting
...Urgent PC system for the treatment of urinary
frequency, urinary urgency and urge incontinence, symptoms often associated
with overactive bladder, and macroplastique
for the treatment of adult
female stress urinary incontinence," said Dave Kaysen, President and Chief
Executive Officer of Uroplasty, Inc. "We also ea...
Uroplasty Reports Third Quarter Fiscal 2009 Results
"Meanwhile, U.S. sales of macroplastique
are building momentum," added Mr.
Kaysen. "Throug...f Macroplastique. The study
concluded that in the macroplastique
patient group, the dry/cure rate was
36.9% versus ...nt group. The authors of the study
concluded that macroplastique
is a safe, effective, minimally invasive